Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junbiao Chang

Showing results (271-280 of 275) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 275 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 11, 2022
A Randomized, Open-Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID-19, a Pilot StudyZhigang Ren, Hong Luo, Zujiang Yu, et al.
Frontiers in Medicine|November 6, 2023
Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patientsSávio Bastos de Souza, Paula Gebe Abreu Cabral, Renato Martins da Silva, et al.
The Journal of Infection|November 19, 2024
Real-world effectiveness and safety of azvudine in hospitalized patients with SARS-CoV-2 infection: A multicenter, retrospective cohort studyZhigang Ren, Mengzhao Yang, Guanyue Su, et al.
Science (New York, N.Y.)|July 20, 2022
TIR-catalyzed ADP-ribosylation reactions produce signaling molecules for plant immunityAolin Jia, Shijia Huang, Wen Song, et al.
Signal Transduction and Targeted Therapy|January 17, 2025
Real-world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort studyHaiyu Wang, Guangying Cui, Ming Cheng, et al.
Pageof 28

Showing results (271-280 of 275) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 275 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 11, 2022
A Randomized, Open-Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID-19, a Pilot StudyZhigang Ren, Hong Luo, Zujiang Yu, et al.
Frontiers in Medicine|November 6, 2023
Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patientsSávio Bastos de Souza, Paula Gebe Abreu Cabral, Renato Martins da Silva, et al.
The Journal of Infection|November 19, 2024
Real-world effectiveness and safety of azvudine in hospitalized patients with SARS-CoV-2 infection: A multicenter, retrospective cohort studyZhigang Ren, Mengzhao Yang, Guanyue Su, et al.
Science (New York, N.Y.)|July 20, 2022
TIR-catalyzed ADP-ribosylation reactions produce signaling molecules for plant immunityAolin Jia, Shijia Huang, Wen Song, et al.
Signal Transduction and Targeted Therapy|January 17, 2025
Real-world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort studyHaiyu Wang, Guangying Cui, Ming Cheng, et al.
Pageof 28